LOGIN
Zoledronic Acid increased hip BMD in acute Charcot neuroarthropathy
September 2013
Zoledronic Acid increased hip BMD in acute Charcot neuroarthropathy
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: A prospective randomized trial
Foot Ankle Surg. 2013 Jun;19(2):121-4. doi: 10.1016/j.fas.2012.12.007. Epub 2013 Feb 20Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
35 patients, suffering from acute midfoot Charcot neuropathy (CNA), were randomized to study the effects of zoledronic acid and immobilization on Bone Mineral Density (BMD) changes in lumbar spine and both hips. Patients were assigned to either receive zoledronic acid or a placebo treatment. 6 month results demonstrated a rise in hip BMD in zoledronic acid-treated group, and a fall in affected and...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.